Anesthesiology Doctors in Cullman, AL Accepting Medicare

8 Anesthesiology doctors found. Showing 1 - 8

Victoria Underwood Clay, MD Anesthesiology - Pain Medicine Medicare: Medicare Enrolled Practice Location: 1948 Al Highway 157 Ste 250, Cullman, AL 35058 Phone: 256-735-5560    Fax: 256-801-7364

Peter Albert Crisologo, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1912 Alabama Hwy 157, Cullman Regional Medical Center, Cullman, AL 35058 Phone: 256-737-2637    Fax: 256-734-6257

Gary Keith Morton, MD Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1912 Al Highway 157, Cullman, AL 35058 Phone: 256-737-2585

James R. Layton, MD Anesthesiology - Pediatric Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1912 Al Highway 157, Cullman, AL 35058 Phone: 256-737-2000

Robin Tate Hall, MD Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1912 Alabama Hwy 157, Cullman Regional Medical Center, Cullman, AL 35058 Phone: 256-737-2638    Fax: 256-734-6257

Ann Christine Still, MD Anesthesiology Medicare: May Accept Medicare Assignments Practice Location: 1701 Main Ave Sw, Suite E, Cullman, AL 35055 Phone: 256-531-9213    Fax: 256-841-6019

Narciso Jauhari Samuy, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1910 Cherokee Ave Sw, Cullman, AL 35055 Phone: 256-739-3500

Kevin Johnson, MD PC Anesthesiology Medicare: Medicare Enrolled Practice Location: 1403 Wall Street, Cullman, AL 35055 Phone: 256-734-9472    Fax: 256-734-9272

News Archive

CVS Caremark's medication adherence program for people with diabetes has positive impact

CVS Caremark said the company's comprehensive adherence program for people with diabetes positively impacts medication adherence for both new and continuing patients. A review of data tracking the program found that 75.6 percent of patients continuing on a diabetes therapy who participated in the adherence program maintained optimal adherence to their prescribed therapy vs. 61.2 percent in the control group.

Mesothelioma.us releases new case study that focuses on experimental treatments for mesothelioma

Mesothelioma.us, an educational and authoritative website that offers free and in-depth resources for mesothelioma patients and their families, has just released a new case study that focuses on the experimental treatments for the disease.

IQWiG finds minor added benefit of dulaglutide in combination with short-acting insulin for type 2 diabetes

Since 2014 dulaglutide has been approved alone or in combination with other drugs for the treatment of adults with type 2 diabetes. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapies.

Combination treatment effective for HCV genotype-1 mono-infected patients

Results presented today at The International Liver Congress 2015 show that the sofosbuvir (SOF)/daclatasvir (DCV) treatment combination is effective amongst hepatitis C virus (HCV) genotype-1 mono-infected patients. These results are significant because whilst other combinations have been widely reported on, there have been few data until now regarding the use of SOF/DCV combination in real world situations.

Read more Medical News

› Verified 1 days ago